Gel Hyaluronic Acid Injections

Interestingly, viscosupplementation appears to provide clinical benefit through a different mechanism than originally believed. The injected HA does not remain in the joint for long and is typically cleared within one to two days. Despite this, pain relief may persist for several months following a single injection or series of injections.

Current research suggests the benefit is primarily anti-inflammatory in nature. In an arthritic joint, HA tends to bind to proteins that contribute to tissue damage and inflammation. Introducing a large volume of HA may displace these inflammatory molecules, reducing their concentration and the symptoms they cause. Multiple studies have documented meaningful improvements in pain and function compared with pre-injection baselines, with some evidence suggesting superiority over other treatment options for up to 26 weeks.

Not all hyaluronic acid products are equivalent. Natural joint fluid is highly viscous, and products whose viscosity more closely resembles native joint fluid are generally considered more effective. Additionally, HA formulations composed of a single, long molecular chain appear to outperform those made from multiple smaller fragments bonded together.

The manufacturing process also matters. HA can be derived from avian sources (bird tissue) or produced through bacterial fermentation. Fermentation-derived HA is generally considered less likely to trigger an immune response, which may otherwise cause temporary swelling in a small subset of patients.

Viscosupplementation may be administered as a single injection or as a series of injections given weekly or every other week over several weeks. Evidence from clinical reviews suggests that multiple-injection regimens tend to provide greater pain relief than a single injection while maintaining a favorable safety profile.

The most commonly reported side effects include temporary pain, swelling, and localized inflammation at the injection site. Allergic reactions are uncommon but possible. Patients with known allergies to eggs, bird feathers, or other avian products should inform Dr. Mark Cinque’s team before treatment. As with any injection that enters the joint, there is a small risk of infection.

When the pain-relieving effects diminish, an additional course of injections may be considered. At least six months should elapse between the initial series and any subsequent treatment, although the optimal interval has not been formally established in clinical studies. Viscosupplementation may be repeated, but its effectiveness can diminish over time and tends to be more limited in patients with advanced osteoarthritis.